CD28
细胞生物学
调节器
效应器
PI3K/AKT/mTOR通路
信号转导
T细胞受体
化学
突变体
受体
细胞内
生物
机制(生物学)
T细胞
Jurkat细胞
细胞骨架
细胞因子
细胞
抗原
负调节器
嵌合抗原受体
配体(生物化学)
细胞信号
激酶
白细胞介素2受体
作者
Hui Chen,Songfang Wu,Yong Zhang,Wei Hu,Changjie Lou,Wei Chen,Jizhong Lou
标识
DOI:10.1073/pnas.2612742123
摘要
T cell activation relies on the coordinated integration of T cell receptor (TCR) and cosignaling pathways, yet how these signals are physically organized remains unclear. Here, we demonstrate that CD28 co-stimulation is driven by a condensation mechanism in which the CD28 intracellular domain (ICD) forms signaling condensates with the Src-family kinase Lck. Ligand engagement promotes CD28 ICD accessibility and triggers rapid CD28/Lck condensation, enhancing CD28 phosphorylation, cytoskeletal polarization, and cytokine production. The downstream effectors of CD28, including PI3K and GRB2, can also be recruited into the CD28-Lck condensates in our reconstituted system. We further identify PD-1 as a graded regulator of this process: Monophosphorylated PD-1 is recruited into CD28/Lck condensates, whereas diphosphorylated PD-1 competitively binds the CD28 ICD and dissolves these assemblies. CD28 and PD-1 ICDs also undergo condensation directly, revealing a dynamic and compositionally heterogeneous signaling system. Guided by this competitive condensation mechanism, we engineer CD28 ICD mutants that preserve Lck condensation while resisting PD-1-mediated disruption. Incorporation of these condensation-selective mutants into Chimeric antigen receptor (CAR) constructs confers resistance to inhibitory signaling and enhances antitumor efficacy in vivo. These findings establish condensation as a central organizing principle of CD28 costimulation and provide a biophysical framework for engineering more resilient therapeutic T cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI